High Content Screening Market

High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User - Global Forecast to 2022

Report Code: BT 2227 Apr, 2017, by marketsandmarkets.com

[166 Pages Report] MarketsandMarkets forecasts the high content screening market to grow from USD 557.1 million in 2017 to USD 909.0 million by 2022, at a Compound Annual Growth Rate (CAGR) of 10.3% during the forecast period. The major factors that are expected to be driving the high content screening market are need for cost containment in pharma R&D, growth in funding for cellular research, and technological advancements in HCS solutions are expected to support the growth of the HCS market during the forecast period. On the other hand, the high cost of HCS instruments and the dearth of knowledgeable and skilled personnel for the operation of high-content screening instruments are expected to restrain the market growth to a certain extent.

High Content Screening Market

By product, the HCS instruments segment is expected to dominate the market

The HCS instruments market accounted for the largest share of HCS market primarily attributed to advances in instrumentation and automation techniques and high prices of the HCS instruments. The software segment is expected to register the highest growth during the forecast period. The growth of this market is attributed to the technological advancements in image acquisition, data analysis, and storage capabilities and the need to obtain information on changes in cell morphology through high-quality images.

By deployment type, the cloud segment to record the highest CAGR during the forecast period

On the basis of application, the high-content screening market is segmented into target identification and validation, primary and secondary screening, toxicity studies, compound profiling, and other applications such as angiogenesis, apoptosis, cell cycle and mitotic index, cell proliferation, endocytosis, protein synthesis, and stem cell differentiation. The primary and secondary screening application segment is expected to grow at highest CAGR during the forecast period. The high growth can primarily be attributed to the wide use of HCS for secondary screening purposes. Growth in the primary and secondary screening segment can also be attributed to the presence of a large number of potential drug candidates for target-specific delivery.

High Content Screening Market

North America to account for the largest market size during the forecast period.

North America is the largest market for high-content screening, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. High R&D expenditure, the presence of major pharmaceutical market players, and increasing government support are some of the factors contributing to the large share of North America in the market. However, the Asia-Pacific market is expected to register the highest growth during the forecast period owing to increased research in drug discovery, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure.

High Content Screening Market

Market Dynamics

Driver: Need for cost containment in pharmaceutical R&D

According to the California Biomedical Research Association (CBRA), it takes an average of 12 years for a drug to travel from the research lab to the patient, including 1–6 years for toxicology studies alone. In addition, only five in 5,000, or 10%, of the drugs that begin preclinical testing ever make it to human testing. Out of these five, only one is approved for human usage. The Tufts Center for the Study of Drug Development (U.S.) report published in the Journal of Health Economics in March 2016 estimates that the average cost to develop and gain a marketing approval for a new drug amounted to USD 2.56 billion. The high cost and long duration of drug development are compelling pharmaceutical companies to revise their R&D expenditure. The conventional method of toxicity studies involves the screening of large libraries in search of potential drug candidates. This method is expensive, resource- & time-consuming, and has a low success rate. Hence, HCS solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in vitro toxicity testing by reducing the time and cost. This is fueling the growth of the high-content screening market and is expected to act as a major driver for this market during the forecast period.

Restraint: Lower adoption of HCS instruments due to their high prices

HCS instruments are equipped with advanced cell imaging and analysis features and functionalities and thus are priced at a premium. A confocal microscope can cost more than USD 200,000. The InCell 2000 Analyzer system (from GE Healthcare) used in HCS costs around USD 240,000. The price for a flow cytometer instrument varies from USD 35,000 for simple cell analyzers to above USD 300,000 for more complex systems with higher throughput. For instance, the CyFlow Cube 6 from Sysmex-Partec costs around USD 35,000. The S3 cell sorter from Bio-Rad Laboratories is priced at USD 150,000 while BD’s FACSJazz costs around USD 240,000. Academic research laboratories find it difficult to afford such instruments, as they have restricted budgets. On the other hand, pharmaceutical companies require many such systems and hence their capital costs increase significantly. Moreover, the maintenance costs and several other indirect expenses increase the total cost of ownership of these instruments. High cost, therefore, hinders the wide adoption of HCS instruments in both clinical and research applications, especially in emerging nations.

Opportunity: Increasing number of CROs providing HCS services

HCS is used in several stages of the drug discovery process, including primary and secondary screening, target identification and validation and toxicity studies. As HCS instruments are expensive, they add to the overall drug development expense for pharmaceutical and biopharmaceutical companies. Moreover, budgetary restrictions among academic institutes restrict the purchase of these instruments. Also, the handling of these equipment requires skilled professionals. As a result, many companies and academic institutes prefer to outsource HCS services to CROs. Due to the rising demand for outsourced service providers in HCS, an increasing number of CROs are offering HCS services. This, in turn, serves as an opportunity for the growth of the HCS market.

Challenge: Dearth of Knowledgeable and skilled operators of HCS instruments

HCS instruments such as flow cytometers and multimode readers have relatively complex technologies. Experts with a good knowledge of cell-based assays and handling software & instruments are required for their optimum utilization. However, there is a significant shortage of skilled personnel in this market. A survey conducted by the Association of the British Pharmaceutical Industry (ABPI) in the U.K. revealed a lack of skilled personnel in pharmaceutical companies. Around 93 employees from 59 pharmaceutical companies participated in the survey. More than 50% respondents in the survey expressed an urgent need to improve the availability of staff in 10 discipline areas. Owing to the shortage of skilled and knowledgeable professionals, companies tend to prefer conventional screening methods of cell-based assays; this presents a significant challenge to the growth of the HCS market.

Scope of the Report

Report Metric

Details

Market size available for years

2015–2022

Base year considered

2016

Forecast period

2017–2022

Forecast units

Million (USD)

Segments covered

Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User

Geographies covered

North America, Europe, APAC, MEA, and Latin America

Companies covered

GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).

The research report categorizes the HCS market to forecast the revenues and analyze the trends in each of the following sub-segments:

Global High-content Screening Market, by Product

  • Instruments   
    • Cell Imaging and Analysis Systems
    • Flow Cytometers
  • Consumables
    • Reagents & Assay Kits
    • Microplates
    • Other Consumables
  • Software        
  • Services         
  • Accessories    

Global High-content Screening Market, by Application

  • Target Identification and Validation
  • Primary Screening and Secondary Screening
  • Toxicity Studies
  • Compound Profiling
  • Other Applications

Global High-content Screening Market, by End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutes
  • Contract Research Organizations (CROs)

Global High-content Screening Market, by Region

  • North America     
    • U.S.
    • Canada
  • Europe     
    • Germany
    • U.K.
    • France
    • Switzerland
    • Rest of Europe
  • Asia-Pacific          
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Latin America      
  • Middle East & Africa

 Key Market Players

GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.)

Danaher Corporation is a market leader of the global high-content screening market. The company designs, manufactures, and markets professional, medical, industrial and commercial products and services. Through its subsidiaries, the company offers solutions in the market. Danaher Corporation primarily focused on product launches as its key business strategy. For example, in February 2017, Molecular Devices, LLC (U.S.), a subsidiary of Danaher Corporation, launched the SpectraMax iD3 Multi-Mode Microplate Reader. This added another platform to the company’s portfolio to expand its reach in the HCS market. Moreover, in April 2016, Molecular Devices, LLC (U.S.) launched the ImageXpress Micro 4 High-Content Imaging System. This further strengthened the HCS product portfolio of the company. The company also focused on acquisitions to improve its market share. In April 2014, Beckman Coulter Life Sciences (U.S.) a subsidiary of Danaher Corporation, (U.S.) acquired flow cytometer developer Xitogen Technologies (China) in order to employ its solutions in basic research experiments.  

Recent Developments

  • In February 2017, Molecular Devices, LLC (U.S.), a subsidiary of Danaher Corporation, launched the SpectraMax iD3 Multi-Mode Microplate Reader, a solution which allows multiple SpectraMax iD3 instruments to be controlled from one workstation using network connectivity. .
  • In January 2017, PerkinElmer, Inc. launched the Vectra Polaris automated quantitative pathology imaging system. This multi-modal tissue imaging system enables researchers to gain a deeper level of understanding of disease mechanisms related to new cancer immunotherapy approaches.
  • In November 2016, Merck Millipore collaborated with Evotec AG (Germany), to provide screening services for Merck’s collection of genetic reagents such as CRISPR and shRNA libraries. With Evotec’s screening expertise, Merck was able to explore and identify new drug targets.
  • In August 2015, Becton, Dickinson and Company acquired Cellular Research, Inc. (U.S.), a biotechnology R&D company. Through this acquisition, BD combined its BD FACS single-cell sorting instrumentation and software with Cellular Research’s Precise assays based on the Molecular Indexing technology to offer customers an integrated workflow for measuring both nucleic acid and protein expression in cellular subtypes.     

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the HCS market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
    1.4 Years Considered for the Study
    1.5 Limitations
    1.6 Currency
    1.7 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Approach
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
           2.3.1 Data From Secondary Sources
           2.3.2 Data From Primary Sources
           2.3.3 Key Industry Insights
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)
    4.1 High-Content Screening: Market Snapshot
    4.2 Europe: Market, By Application (2016)
    4.3 Geographic Snapshot of the Market
    4.4 Market: Regional Mix

5 Market Overview (Page No. - 36)
    5.1 Introduction
    5.2 Key Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Need for Cost Containment in Pharmaceutical R&D
                    5.2.1.2 Government Funding and Venture Capital Investments Across Developed Markets
                    5.2.1.3 Advancements in Informatics Solutions and Imaging Instruments
           5.2.2 Market Restraints
                    5.2.2.1 Lower Adoption of HCS Instruments Due to Their High Prices
           5.2.3 Market Opportunities
                    5.2.3.1 Increasing Number of Cros Providing HCS Services
                    5.2.3.2 Application of HCS in Personalized Medicine
           5.2.4 Market Challenges
                    5.2.4.1 Dearth of Knowledgeable and Skilled Operators of HCS Instruments
                    5.2.4.2 Inadequate Infrastructure and Funding for R&D in Emerging Countries

6 Industry Insights (Page No. - 44)
    6.1 Industry Trends
           6.1.1 Rising Adoption of Label-Free Technologies
           6.1.2 Growing Focus on Stem Cell Analysis
    6.2 Technological Roadmap

7 Global High-Content Screening Market, By Product (Page No. - 47)
    7.1 Introduction
    7.2 Instruments
           7.2.1 Cell Imaging and Analysis Systems
                    7.2.1.1 Global Cell Imaging and Analysis Systems Market Size, By Region/Country
           7.2.2 Flow Cytometers
                    7.2.2.1 Cell Analyzers
                               7.2.2.1.1 Global Cell Analyzers Market Size, By Region/Country
                    7.2.2.2 Cell Sorters
                               7.2.2.2.1 Global Cell Sorters Market Size, By Region/Country
    7.3 Consumables
           7.3.1 Reagents & Assay Kits
                    7.3.1.1 Global Reagents and Assay Kits Market Size, By Region/Country
           7.3.2 Microplates
                    7.3.2.1 Global Microplates Market Size, By Region/Country
           7.3.3 Other Consumables
                    7.3.3.1 Global Other Consumables Market Size, By Region/Country
    7.4 Software
           7.4.1 Global High-Content Screening Software Market Size, By Region/Country
    7.5 Services
           7.5.1 Global High-Content Screening Services Market Size, By Region/Country
    7.6 Accessories

8 Global High-Content Screening Market, By Application (Page No. - 63)
    8.1 Introduction
    8.2 Primary and Secondary Screening
           8.2.1 Global Market Size For Primary and Secondary Screening, By Country
    8.3 Target Identification and Validation
           8.3.1 Global Market Size For Target Identification and Validation, By Country
    8.4 Toxicity Studies
           8.4.1 Global Market Size For Toxicity Studies, By Country
    8.5 Compound Profiling
           8.5.1 Global Market Size For Compound Profiling, By Country
    8.6 Other Applications
           8.6.1 Global High-Content Screening Market Size For Other Applications, By Country

9 Global High-Content Screening Market, By End User (Page No. - 70)
    9.1 Introduction
    9.2 Pharmaceutical and Biotechnology Companies
           9.2.1 Global Market Size For Pharmaceutical and Biotechnology Companies, By Country
    9.3 Academic and Government Institutes
           9.3.1 Global Market Size For Academic and Government Institutes, By Country
    9.4 Contract Research Organizations
           9.4.1 Global Market Size For Contract Research Organizations, By Country

10 High-Content Screening Market, By Region (Page No. - 75)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
                        10.2.1.1 U.S.: High-Content Screening Market Size, By Product
                        10.2.1.2 U.S.: High-Content Screening Instruments Market Size, By Type
                        10.2.1.3 U.S.: Flow Cytometers Market Size, By Type
                        10.2.1.4 U.S.: High-Content Screening Consumables Market Size, By Type
                        10.2.1.5 U.S.: Market Size, By Application
                        10.2.1.6 U.S.: Market Size, By End User
             10.2.2 Canada
                        10.2.2.1 Canada: Market Size, By Product
                        10.2.2.2 Canada: High-Content Screening Instruments Market Size, By Type
                        10.2.2.3 Canada: Flow Cytometers Market Size, By Type
                        10.2.2.4 Canada: High-Content Screening Consumables Market Size, By Type
                        10.2.2.5 Canada: High-Content Screening Market Size, By Application
                        10.2.2.6 Canada: Market Size, By End User
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Germany: Market Size, By Product
                        10.3.1.2 Germany: High-Content Screening Instruments Market Size, By Type
                        10.3.1.3 Germany: Flow Cytometers Market Size, By Type
                        10.3.1.4 Germany: High-Content Screening Consumables Market Size, By Type
                        10.3.1.5 Germany: High-Content Screening Market Size, By Application
                        10.3.1.6 Germany: Market Size, By End User
             10.3.2 U.K.
                        10.3.2.1 U.K.: High-Content Screening Market Size, By Product
                        10.3.2.2 U.K.: High-Content Screening Instruments Market Size, By Type
                        10.3.2.3 U.K.: Flow Cytometers Market Size, By Type
                        10.3.2.4 U.K.: High-Content Screening Consumables Market Size, By Type
                        10.3.2.5 U.K.: Market Size, By Application
                        10.3.2.6 U.K.: Market Size, By End User
             10.3.3 France
                        10.3.3.1 France: High-Content Screening Market Size, By Product
                        10.3.3.2 France: High-Content Screening Instruments Market Size, By Type
                        10.3.3.3 France: Flow Cytometers Market Size, By Type
                        10.3.3.4 France: High-Content Screening Consumables Market Size, By Type
                        10.3.3.5 France: Market Size, By Application
                        10.3.3.6 France: Market Size, By End User
             10.3.4 Switzerland
                        10.3.4.1 Switzerland: High-Content Screening Market Size, By Product
                        10.3.4.2 Switzerland: High-Content Screening Instruments Market Size, By Type
                        10.3.4.3 Switzerland: Flow Cytometers Market Size, By Type
                        10.3.4.4 Switzerland: High-Content Screening Consumables Market Size, By Type
                        10.3.4.5 Switzerland: High-Content Screening Market Size, By Application
                        10.3.4.6 Switzerland: Market Size, By End User
             10.3.5 Rest of Europe
                        10.3.5.1 Rest of Europe: High-Content Screening Market Size, By Product
                        10.3.5.2 Rest of Europe: High-Content Screening Instruments Market Size, By Type
                        10.3.5.3 Rest of Europe: Flow Cytometers Market Size, By Type
                        10.3.5.4 Rest of Europe: High-Content Screening Consumables Market Size, By Type
                        10.3.5.5 Rest of Europe: Market Size, By Application
                        10.3.5.6 Rest of Europe: Market Size, By End User
     10.4 Asia-Pacific
             10.4.1 Japan
                        10.4.1.1 Japan: High-Content Screening Market Size, By Product
                        10.4.1.2 Japan: High-Content Screening Instruments Market Size, By Type
                        10.4.1.3 Japan: Flow Cytometers Market Size, By Type
                        10.4.1.4 Japan: High-Content Screening Consumables Market Size, By Type
                        10.4.1.5 Japan: Market Size, By Application
                        10.4.1.6 Japan: Market Size, By End User
             10.4.2 China
                        10.4.2.1 China: Market Size, By Product
                        10.4.2.2 China: High-Content Screening Instruments Market Size, By Type
                        10.4.2.3 China: Flow Cytometers Market Size, By Type
                        10.4.2.4 China: High-Content Screening Consumables Market Size, By Type
                        10.4.2.5 China: High-Content Screening Market Size, By Application
                        10.4.2.6 China: Market Size, By End User
             10.4.3 India
                        10.4.3.1 India: Market Size, By Product
                        10.4.3.2 India: High-Content Screening Instruments Market Size, By Type
                        10.4.3.3 India: Flow Cytometers Market Size, By Type
                        10.4.3.4 India: High-Content Screening Consumables Market Size, By Type
                        10.4.3.5 India: Market Size, By Application
                        10.4.3.6 India: Market Size, By End User
             10.4.4 Rest of Asia-Pacific
                        10.4.4.1 Roapac: High-Content Screening Market Size, By Product
                        10.4.4.2 Roapac: High-Content Screening Instruments Market Size, By Type
                        10.4.4.3 Roapac: Flow Cytometers Market Size, By Type
                        10.4.4.4 Roapac: High-Content Screening Consumables Market Size, By Type
                        10.4.4.5 Roapac: High-Content Screening Market Size, By Application
                        10.4.4.6 Roapac: Market Size, By End User
     10.5 Latin America
             10.5.1 Latin America: Market Size, By Product
             10.5.1 Latin America: High-Content Screening Instruments Market Size, By Type
             10.5.1 Latin America: Flow Cytometers Market Size, By Type
             10.5.1 Latin America: High-Content Screening Consumables Market Size, By Type
             10.5.1 Latin America: Market Size, By Application
             10.5.1 Latin America: Market Size, By End User
     10.6 Middle East and Africa
             10.6.1 MEA: High-Content Screening Market Size, By Product
             10.6.2 MEA: High-Content Screening Instruments Market Size, By Type
             10.6.3 Switzerland: Flow Cytometers Market Size, By Type
             10.6.4 MEA: High-Content Screening Consumables Market Size, By Type
             10.6.5 MEA: Market Size, By Application
             10.6.6 MEA: Market Size, By End User

11 Competitive Landscape (Page No. - 117)
     11.1 Overview
     11.2 Competitive Analysis
             11.2.1 Market Players Ranking
             11.2.2 Product Matrix
             11.2.3 Vendor Benchmarking
     11.3 Competitive Situations and Trends
             11.3.1 Product Launches
             11.3.2 Collaborations, Partnerships, and Agreements
             11.3.3 Acquisitions
             11.3.4 Expansions

12 Company Profiles (Page No. - 128)
(Overview, Products and Services, Financials, Strategy & Development)*
     12.1 Introduction
     12.2 Ge Healthcare
             12.2.1 Business Overview
             12.2.2 Products Offered
             12.2.3 Recent Development
             12.2.4 MnM View
     12.3 Danaher Corporation
             12.3.1 Business Overview
             12.3.2 Products Offered
             12.3.3 Recent Development
             12.3.4 MnM View
     12.4 Perkinelmer, Inc.
             12.4.1 Business Overview
             12.4.2 Products Offered
             12.4.3 Recent Development
             12.4.4 MnM View
     12.5 Thermo Fisher Scientific Inc.
             12.5.1 Business Overview
             12.5.2 Products Offered
             12.5.3 Recent Development
             11.5.4 MnM View
     12.6 Becton, Dickinson and Company
             12.6.1 Business Overview
             12.6.2 Products Offered
             12.6.3 Recent Development
             12.6.4 MnM View
     12.7 Biotek Instruments, Inc.
             12.7.1 Business Overview
             12.7.2 Products Offered
             12.7.3 Recent Development
     12.8 Bio-Rad Laboratories, Inc.
             12.8.1 Business Overview
             12.8.2 Products Offered
             12.8.3 Recent Development
     12.9 Tecan Group Ltd.
             12.9.1 Business Overview
             12.9.2 Products Offered
             12.9.3 Recent Development
     12.10 Yokogawa Electric Corporation
             12.10.1 Business Overview
             12.10.2 Products Offered
             12.10.3 Recent Development
     12.11 Merck Millipore
             12.11.1 Business Overview
             12.11.2 Products Offered
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 154)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments
     13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.5 Introducing RT: Real-Time Market Intelligence
     13.6 Available Customizations
     13.7 Related Reports
     13.8 Author Details


List of Tables (138 Tables)

Table 1 Market Drivers: Impact Analysis
Table 2 Market Restraints: Impact Analysis
Table 3 Market Opportunities: Impact Analysis
Table 4 Market Challenges: Impact Analysis
Table 5 Global HCS Market Size, By Product, 2015-2022 (USD Million)
Table 6 Global HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 7 Global HCS Instruments Market Size, By Country/Region, 2015-2022 (USD Million)
Table 8 Global Cell Imaging and Analysis Systems Market Size, By Country/Region, 2015-2022 (USD Million)
Table 9 Global Flow Cytometers Market Size, By Type, 2015–2022 (USD Million)
Table 10 Global Flow Cytometers Market Size, By Region/Country, 2015–2022 (USD Million)
Table 11 Global Cell Analyzers Market Size, By Region/Country, 2015-2022 (USD Million)
Table 12 Global Cell Sorters Market Size, By Region/Country, 2015-2022 (USD Million)
Table 13 Global HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 14 Global HCS Consumables Market Size, By Region/Country, 2015-2022 (USD Million)
Table 15 Global Reagents and Assay Kits Market Size, By Region/Country, 2015-2022 (USD Million)
Table 16 Global Microplates Market Size, By Region/Country, 2015-2022 (USD Million)
Table 17 Global Other Consumables Market Size, By Region/Country, 2015-2022 (USD Million)
Table 18 Global HCS Software Market Size, By Region/Country, 2015-2022 (USD Million)
Table 19 Global HCS Services Market Size, By Region/Country, 2015-2022 (USD Million)
Table 20 Global HCS Accessories Market Size, By Region/Country, 2015-2022 (USD Million)
Table 21 Global HCS Market Size, By Application, 2015-2022 (USD Million)
Table 22 Global High-Content Screening Market Size for Primary and Secondary Screening, By Country, 2015-2022 (USD Million)
Table 23 Global Market Size for Target Identification and Validation, By Country, 2015-2022 (USD Million)
Table 24 Global Market Size for Toxicity Studies, By Country, 2015-2022 (USD Million)
Table 25 Global Market Size for Compound Profiling, By Country, 2015-2022 (USD Million)
Table 26 Global Market Size for Other Applications, By Country, 2015-2022 (USD Million)
Table 27 Global Market Size, By End User, 2015-2022 (USD Million)
Table 28 Global Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2015-2022 (USD Million)
Table 29 Global Market Size for Academic and Government Institutes, By Country, 2015-2022 (USD Million)
Table 30 Global Market Size for Contract Research Organizations, By Country, 2015-2022 (USD Million)
Table 31 Global Market, By Region, 2015-2022 (USD Million)
Table 32 North America: Market Size, By Country, 2015-2022 (USD Million)
Table 33 North America: Market Size, By Product, 2015-2022 (USD Million)
Table 34 North America: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 35 North America: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 36 North America: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 37 North America: Market Size, By Application, 2015-2022 (USD Million)
Table 38 North America: Market Size, By End User, 2015-2022 (USD Million)
Table 39 U.S.: HCS Market Size, By Product, 2015-2022 (USD Million)
Table 40 U.S.: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 41 U.S.: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 42 U.S.: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 43 U.S.: High-Content Screening Market Size, By Application, 2015-2022 (USD Million)
Table 44 U.S.: Market Size, By End User, 2015-2022 (USD Million)
Table 45 Canada: Market Size, By Product, 2015-2022 (USD Million)
Table 46 Canada: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 47 Canada: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 48 Canada: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 49 Canada: Market Size, By Application, 2015-2022 (USD Million)
Table 50 Canada: Market Size, By End User, 2015-2022 (USD Million)
Table 51 Pharmaceutical R&D Expenditure in Europe, By Country, 2014 (USD Million)
Table 52 Europe: Market Size, By Country, 2015-2022 (USD Million)
Table 53 Europe: Market Size, By Product, 2015-2022 (USD Million)
Table 54 Europe: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 55 Europe: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 56 Europe: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 57 Europe: Market Size, By Application, 2015-2022 (USD Million)
Table 58 Europe: Market Size, By End User, 2015-2022 (USD Million)
Table 59 Germany: Market Size, By Product, 2015-2022 (USD Million)
Table 60 Germany: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 61 Germany: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 62 Germany: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 63 Germany: Market Size, By Application, 2015-2022 (USD Million)
Table 64 Germany: HCS Market Size, By End User, 2015-2022 (USD Million)
Table 65 U.K.: Market Size, By Product, 2015-2022 (USD Million)
Table 66 U.K.: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 67 U.K.: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 68 U.K.: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 69 U.K.: Market Size, By Application, 2015-2022 (USD Million)
Table 70 U.K.: Market Size, By End User, 2015-2022 (USD Million)
Table 71 France: Market Size, By Product, 2015-2022 (USD Million)
Table 72 France: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 73 France: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 74 France: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 75 France: Market Size, By Application, 2015-2022 (USD Million)
Table 76 France: Market Size, By End User, 2015-2022 (USD Million)
Table 77 Switzerland: Market Size, By Product, 2015-2022 (USD Million)
Table 78 Switzerland:HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 79 Switzerland: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 80 Switzerland: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 81 Switzerland: Market Size, By Application, 2015-2022 (USD Million)
Table 82 Switzerland: Market Size, By End User, 2015-2022 (USD Million)
Table 83 Rest of Europe: Market Size, By Product, 2015-2022 (USD Million)
Table 84 Rest of Europe: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 85 Rest of Europe: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 86 Rest of Europe: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 87 Rest of Europe: Market Size, By Application, 2015-2022 (USD Million)
Table 88 Rest of Europe: Market Size, By End User, 2015-2022 (USD Million)
Table 89 Asia-Pacific: Market Size, By Country, 2015-2022 (USD Million)
Table 90 Asia-Pacific: Market Size, By Product, 2015-2022 (USD Million)
Table 91 Asia-Pacific: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 92 Asia-Pacific: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 93 Asia-Pacific: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 94 Asia-Pacific: High-Content Screening Market Size, By Application, 2015-2022 (USD Million)
Table 95 Asia-Pacific: Market Size, By End User, 2015-2022 (USD Million)
Table 96 Japan: Market Size, By Product, 2015-2022 (USD Million)
Table 97 Japan: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 98 Japan: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 99 Japan: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 100 Japan: Market Size, By Application, 2015-2022 (USD Million)
Table 101 Japan: Market Size, By End User, 2015-2022 (USD Million)
Table 102 China: High-Content Screening Market Size, By Product, 2015-2022 (USD Million)
Table 103 China: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 104 China: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 105 China: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 106 China: Market Size, By Application, 2015-2022 (USD Million)
Table 107 China: Market Size, By End User, 2015-2022 (USD Million)
Table 108 India: Market Size, By Product, 2015-2022 (USD Million)
Table 109 India: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 110 India: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 111 India: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 112 India: Market Size, By Application, 2015-2022 (USD Million)
Table 113 India: Market Size, By End User, 2015-2022 (USD Million)
Table 114 Rest of Asia-Pacific: Market Size, By Product, 2015-2022 (USD Million)
Table 115 Rest of Asia-Pacific: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 116 Rest of Asia-Pacific: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 117 Rest of Asia-Pacific: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 118 Rest of Asia-Pacific: Market Size, By Application, 2015-2022 (USD Million)
Table 119 Rest of Asia-Pacific: Market Size, By End User, 2015-2022 (USD Million)
Table 120 Latin America: Market Size, By Product, 2015-2022 (USD Million)
Table 121 Latin America: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 122 Latin America: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 123 Latin America: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 124 Latin America: Market Size, By Application, 2015-2022 (USD Million)
Table 125 Latin America: Market Size, By End User, 2015-2022 (USD Million)
Table 126 Middle East and Africa: High-Content Screening Market Size, By Product, 2015-2022 (USD Million)
Table 127 Middle East and Africa: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 128 Middle East and Africa: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 129 Middle East and Africa: High-Content Screening Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 130 Middle East and Africa: Market Size, By Application, 2015-2022 (USD Million)
Table 131 Middle East and Africa: Market Size, By End User, 2015-2022 (USD Million)
Table 132 Global Market Ranking, By Key Player, 2016
Table 133 Market: Product Matrix
Table 134 Growth Strategy Matrix (2014–2017)
Table 135 Product Launches, 2014–2017
Table 136 Collaborations, Partnerships, and Agreements, 2014–2017
Table 137 Acquisitions, 2014–2017
Table 138 Expansions, 2014–2017


List of Figures (42 Figures)

Figure 1 Global High-Content Screening Market Segmentation
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 7 Global High-Content Screening Market Size, By Product, 2017 vs 2022 (USD Million)
Figure 8 Global Market Size, By Application, 2017 vs 2022 (USD Million)
Figure 9 Global Market Size, By End User, 2017 vs 2022 (USD Million)
Figure 10 Geographic Snapshot of the Global Market
Figure 11 The Market is Projected to Witness A Double-Digit Growth Rate in the Forecast Period
Figure 12 Germany Commanded the Largest Share of the European Market in 2016
Figure 13 The U.S. Accounted for the Largest Share of the Market in 2016
Figure 14 APAC to Register the Highest CAGR During the Forecast Period
Figure 15 High-Content Screening Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Estimated Pre-Approval Cost of Bringing A New Chemical Or Biological Entity to Market (USD Million)
Figure 17 R&D Expenditure as Percentage of GDP, 2014
Figure 18 Focus on Stem Cell Analysis and Label-Free HCS are the Major Trends in the Market
Figure 19 High-Content Screening: Technological Evolution
Figure 20 Instruments Dominate the Global Market in 2017
Figure 21 Cell Imaging and Analysis Systems to Dominate the High-Content Screening Instruments Market By 2022
Figure 22 Cell Anyalyzers Segment to Register Highest Growth During the Forecast Period
Figure 23 Primary & Secondary Screening Segment to Register the Highest Growth in the HCS Market During the Forecast Period
Figure 24 Global High-Content Screening Market Size, By End User, 2017 vs 2022 (USD Million)
Figure 25 Geographic Snapshot: Market
Figure 26 North America Will Continue to Dominate the Market By 2022
Figure 27 North America: Market Snapshot
Figure 28 Europe: Market Snapshot
Figure 29 Asia-Pacific: Market Snapshot
Figure 30 Product Launches Was the Most-Preferred Strategy Between 2014 and 2017
Figure 31 High-Content Screening: Vendor Benchmarking
Figure 32 Battle for Market Share: Product Launches - the Most Widely Adopted Strategy Between 2014 and 2017
Figure 33 Geographical Revenue Mix of the Top 5 Players in the High-Content Screening Market
Figure 34 GE Healthcare: Company Snapshot (2016)
Figure 35 Danaher Corporation: Company Snapshot (2016)
Figure 36 Perkinelmer, Inc.: Company Snapshot (2016)
Figure 37 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 38 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 39 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 40 Tecan Group Ltd.: Company Snapshot (2016)
Figure 41 Yokogawa Electric Corporation: Company Snapshot (2015)
Figure 42 Merck Millipore: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 2227
Published ON
Apr, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the High Content Screening Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home